Everything below concerns REV-ERB agonist. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-04-15. Numbers and descriptions here follow the published literature rather than marketing material.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
| Property | Value | Notes |
|---|---|---|
| Appearance | Off-white to pale yellow solid | Visual description varies with purity and source |
| Solubility | Soluble in DMSO and ethanol; poorly soluble in water | Organic stock solutions are common in research |
| Typical storage | -20 °C, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Typical analytical method | LC-MS or HPLC-UV | Reference standards are needed for quantification |
| Molar mass | Approximately 437.9 g/mol | Calculated from the reported free-base formula |
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
Examples of iron-containing proteins in higher organisms include hemoglobin, cytochrome (see high-valent iron), and catalase. The average adult human contains about 0.005% body weight of iron, or about four grams, of which three quarters is in hemoglobin—a level that remains constant despite only about one milligram of iron being absorbed each day, because the human body recycles its hemoglobin for the iron content. Microbial growth may be assisted by oxidation of iron(II) or by reduction of iron(III).
sIBM causes progressive muscle weakness. How sIBM affects individuals is variable, including the age of onset (which generally varies from the forties upwards) and rate of progression. Because of this variability, there is no "textbook case". Common early symptoms include frequent tripping and falling and difficulty going up stairs. Foot drop in one or both feet can occur. Part of the cause for this dysfunction is the early involvement of the quadriceps muscles. Weakness of the tibialis anterior muscle is responsible for foot drop. Another common early symptom is trouble manipulating the fingers, such as difficulty with tasks such as turning doorknobs or gripping keys. Weakness of finger flexion and ankle dorsiflexion occurs early. sIBM also preferentially affects the wrist flexors, biceps, and triceps. During the course of the illness, the patient's mobility is progressively restricted as it becomes difficult to bend down, reach for things, and walk quickly. Many patients say they have balance problems and fall easily, as the muscles cannot compensate for an off-balanced posture. Because sIBM makes the leg muscles weak and unstable, patients are very vulnerable to serious injury from tripping or falling down. Although pain has not been traditionally part of the "textbook" description, many patients report severe muscle pain, especially in the thighs.
The Senate resolution had the effect of identifying the U.S. with the effort to remove Noriega; Noriega exploited the rising anti-American sentiment to strengthen his own position. Without the support of the U.S., Panama defaulted on its international debt, and that year the country's economy shrank by 20%. Though the U.S. considered not recognizing Delvalle as president, the State Department decided against it, as it would have amounted to breaking relations with Noriega.
Kidder died on May 13, 2018, at her home in Livingston, Montana, at the age of 69. Her death was ruled a suicide by a "self-inflicted drug and alcohol overdose". Kidder had been scheduled to appear at the Motor City Comic Con in Novi, Michigan, later that week. DC Comics stated on its Twitter feed: "Thank you for being the Lois Lane so many of us grew up with. RIP, Margot Kidder." After her death, director Ted Geoghegan, who knew the actress, stated:
== History == In the late 1950s and early 1960s, the French molecular biologists François Jacob and Jacques Monod became the first to explain enzyme induction, in the context of the lac operon of Escherichia coli. In the absence of lactose, the constitutively expressed lac repressor protein binds to the operator region of the DNA and prevents the transcription of the operon genes. When present, lactose binds to the lac repressor, causing it to separate from the DNA and thereby enabling transcription to occur. Monod and Jacob generated this theory following 15 years of work by them and others (including Joshua Lederberg), partially as an explanation for Monod's observation of diauxie. Previously, Monod had hypothesized that enzymes could physically adapt themselves to new substrates; a series of experiments by him, Jacob, and Arthur Pardee eventually demonstrated this to be incorrect and led them to the modern theory, for which he and Jacob shared the 1965 Nobel Prize in Physiology or Medicine (together with André Lwoff).
Sources: en.wikipedia.org
Chondrocytes can be prepared by sequential enzymatic digestion of cartilage with Pronase and Collagenase and cultured in DMEM-F12 cell culture media. Transplantation of dedifferentiated chondrocytes often leads to the formation of fibrous tissue formation. Redifferentiation of dedifferentiated chondrocytes in the 3-D system (spheroid culture) restore morphological and functional properties. Carticel is a procedure for restoring articular knee cartilage with autologous chondrocyte implantation; it was the first cell therapy to be approved by the U.S. Food and Drug Administration, under accelerated approval in 1997. In Australia, Ortho-ACI, a suspension of cultured autologous chondrocytes, is indicated for use in the treatment of cartilage lesions associated with the knee, patella, and ankle. Chondronectin Endochondral ossification Intramembranous ossification List of human cell types derived from the germ layers List of distinct cell types in the adult human body Histology image: 03317loa – Histology Learning System at Boston University Stem cell information
The ENCODE project proposes to map all of the DHSs in the human genome with the intention of cataloging human regulatory DNA. DHSs mark transcriptionally active regions of the genome, where there will be cellular selectivity. So, they used 125 different human cell types. This way, using the massive sequencing technique, they obtained the DHSs profiles of every cellular type. Through an analysis of the data, they identified almost 2.9 million distinct DHSs. 34% were specific to each cell type, and only a small minority (3,692) were detected in all cell types. Also, it was confirmed that only 5% of DHSs were found in TSS (Transcriptional Start Site) regions. The remaining 95% represented distal DHSs, divided in a uniform way between intronic and intergenic regions. The data gives an idea of the great complexity regulating the genetic expression in the human genome and the quantity of elements that control this regulation. The high-resolution mapping of DHSs in the model plant Arabidopsis thaliana has been reported. Total 38,290 and 41,193 DHSs in leaf and flower tissues have been identified, respectively.
Naturally occurring niobium (41Nb) is composed of one stable isotope (93Nb). The most stable radioisotope is 92Nb with a half-life of 34.7 million years, followed by 94Nb at a half-life of 20,400 years and 91Nb at 680 years. Other radioisotopes that have been synthesized range from 82Nb to 110Nb; these have half-lives that are less than two hours, except 95Nb (34.991 days), 96Nb (23.35 hours) and 90Nb (14.60 hours). The most stable of the meta states is 93mNb with excitation energy 31 keV and a 16.1 year half-life; this is produced in the decay of 93Zr. The primary decay mode before stable 93Nb is electron capture to zirconium isotopes and the primary mode after is beta emission, with delayed neutron emission starting at 104Nb, leading to molybdenum isotopes. Only 95Nb, along with 97Nb (72 minutes) and heavier isotopes (seconds) are fission products in significant quantity, as the other isotopes are shadowed by stable or very long-lived (93) isotopes of the preceding element zirconium from the usual mode of production through beta decay of neutron-rich fission fragments. 95Nb is the decay product of 95Zr (64 days), so disappearance of 95Nb in used nuclear fuel is slower than would be expected from its own 35-day half-life alone.
On the same day, a study reports the assembly of 43 diverse Y chromosomes, revealing large variability such as a range in size from 45.2 to 84.9 million base-pairs. A study indicates factors contributing to the longevity of long-living organisms can be transferred between species, particularly from naked mole-rats to mice. 28 August A study estimates that global warming of 2 °C could result in the mass deaths of 1 billion people by 2100. Astronomers film an impact event, likely by an asteroid, on the planet Jupiter. Researchers demonstrate in two separate studies that quantum simulators, e.g. using trapped ions, can be used to directly observe quantum effects at time-scales far beyond prior approaches, slowing down femtosecond-scale photo-chemical reactions or dynamics around conical intersections 100 billion times. A preprint models Earth as seen from TRAPPIST-1e and indicates that from this 41 light-years distant vantage point, human civilization would be detectable with the James Webb Space Telescope due to atmospheric signatures including air pollution. 30 August – Autonomous drones win first races against human champions of FPV drone racing. 31 August – Researchers report, based on genetic studies, that a human ancestor population bottleneck (from a possible 100,000 to 1,000 individuals) occurred "around 930,000 and 813,000 years ago ... lasted for about 117,000 years and brought human ancestors close to extinction."
Sources: en.wikipedia.org
Two years prior, the French had refused Ho's proposal of a similar status within the French Union, albeit with some restrictions on French power and the latter's eventual withdrawal from Vietnam. However, they were willing to deal with Bảo Đại as he represented a non-radical option who could rally behind him the non-Communist nationalist movement. In January 1950, France officially recognized the nominal "independence" of the unified State of Vietnam, led by Bảo Đại, as an associated state within the French Union. However, France still controlled all foreign policy, every defense issue and would have a French Union army stationed in the country with complete freedom of movement. Within the framework of the French Union, France also granted independence to the other nations in Indochina, the Kingdoms of Laos and Cambodia. In January 1949, the Vietnamese National Army was created to go along the formation of the new Vietnamese associated state. This was meant to bolster French numbers as their army found itself outnumbered by the People's Army of Vietnam at this point in the war. To this end, the CEFEO provided some of its officers to lead these new divisions.
== External links == This page was reproduced (with modifications) with expressed consent from Dr. A. Malcolm Campbell. As of 2010, the original page can be found at Campbell AM (2003). "Protein Crystallization". Davidson, NC: Department of Biology, Davidson College.
=== Bioaccumulation and biomagnification === In marine species of the food web Bioaccumulation controls internal concentrations of pollutants, including PFAS, in individual organisms. When bioaccumulation is looked at in the perspective of the entire food web, it is called biomagnification, which is important to track because lower concentrations of pollutants in environmental matrices such as seawater or sediments, can very quickly grow to harmful concentrations in organisms at higher trophic levels, including humans. Notably, concentrations in biota can even be greater than 5000 times those present in water for PFOS and C10–C14 PFCAs. PFAS can enter an organism by ingestion of sediment, through the water, or directly via their diet. It accumulates mainly in areas with high protein content, in the blood and liver, but it is also found to a lesser extent in tissues.
Sources: en.wikipedia.org
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.
The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.
Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.